Showing results (471-480 of 966) with videos related to
Sort By:
Pageof 97
Nature Reviews. Clinical Oncology|January 6, 2026
Advances in the management of localized bladder cancersMarie-Pier St-Laurent, Jussi Nikkola, Eisuke Tomiyama, et al.Nature Reviews. Clinical Oncology|January 6, 2026
The actionable transcriptome: a framework for incorporating RNA sequencing into precision oncologyAmber Johnson, Yifei Shen, Xiaofeng Zheng, et al.Nature Reviews. Clinical Oncology|September 19, 2025
Next-generation T cell immunotherapies engineered with CRISPR base and prime editing: challenges and opportunitiesKarl Petri, Elvira D'Ippolito, Annette Künkele, et al.Nature Reviews. Clinical Oncology|July 10, 2025
Therapeutic targeting of mismatch repair-deficient cancersPaul Johannet, Benoit Rousseau, Carol Aghajanian, et al.Nature Reviews. Clinical Oncology|July 18, 2025
Evolving roles of MET as a therapeutic target in NSCLC and beyondJii Bum Lee, Joo Sung Shim, Byoung Chul ChoNature Reviews. Clinical Oncology|October 2, 2025
Optimizing CAR T cell therapy for solid tumours: a clinical perspectiveJiarui Li, Chang Liu, Panpan Zhang, et al.Nature Reviews. Clinical Oncology|February 3, 2026
Tailoring targeted therapies for younger women with ER-positive early-stage breast cancerSoraia Lobo-Martins, Stephen J Luen, Martine Piccart, et al.Nature Reviews. Clinical Oncology|June 17, 2025
The next generation of immunotherapies for lung cancersShen Zhao, Hongyun Zhao, Weiwei Yang, et al.Nature Reviews. Clinical Oncology|June 9, 2025
Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancerLi-Bo Tang, Ying-Long Peng, Ji Chen, et al.Nature Reviews. Clinical Oncology|June 9, 2023
Optimizing the safety of antibody-drug conjugates for patients with solid tumoursPaolo Tarantino, Biagio Ricciuti, Shan M Pradhan, et al.Pageof 97